Large Molecule Drug Substance CDMO Market Strengthens with Next-Generation Cell Culture Technologies
The Large Molecule Drug Substance CDMO Market continues to evolve as pharmaceutical and biotechnology companies expand their focus on biologics, biosimilars, and advanced therapeutic products. Increasing demand for specialized manufacturing capabilities, regulatory expertise, and scalable production facilities has positioned contract development and manufacturing organizations (CDMOs) as...
0 Commentarios 0 Acciones 21 Views 0 Vista previa